American Bio Medica Corporation filed its 10-K on Mar 21, 2023 for the period ending Dec 31, 2022. In this report its auditor, Rosenfield & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
American Bio Medica Corporation
Equities
ABMC
US0246001087
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2023 | American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.81K | |
-8.60% | 11.98B | |
-5.68% | 8B | |
+7.10% | 5.85B | |
+26.69% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-61.72% | 2.62B | |
-8.22% | 2.33B | |
+11.42% | 2B |
- Stock Market
- Equities
- ABMC Stock
- News American Bio Medica Corporation
- American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt